May 4 |
Pharma R&D productivity seen improving for the first time in years - Deloitte
|
May 3 |
Here's Why Merck (MRK) is a Strong Momentum Stock
|
May 3 |
Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected
|
May 2 |
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
|
May 2 |
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
|
May 1 |
15 Best Places to Retire in Florida That You’ve Never Heard Of
|
May 1 |
Merck Keytruda combo meets main goal in late-stage trial for advanced gastric cancer
|
May 1 |
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
|
May 1 |
3 Pharma Stocks With the Potential to Make You an Overnight Millionaire
|
Apr 30 |
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
|